Holen Sie sich die Stockscreener-App
8.895
1.82%
-0.165
Vorhandelsmarkt:
8.95
0.055
+0.62%
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.192 | 0.249 | - |
| Cost Of Revenue |
-
|
- | - | -0.714 | 0.343 |
| Costs And Expenses |
31.68%
19.32
|
14.67 | 13.50 | 13.11 | 9.575 |
| Operating Income/Loss |
31.68%
-19.32
|
-14.67 | -13.31 | -12.86 | -9.575 |
| Nonoperating Income/Loss |
193.78%
-1.433
|
1.528 | -21.91 | 35.88 | 108.05 |
| Income/Loss From Continuing Operations Before Tax |
57.90%
-20.75
|
-13.14 | -35.23 | 23.02 | 98.47 |
| Income Tax Expense/Benefit, Deferred |
100.00%
0.016
|
0.008 | 0.114 | -0.014 | 0.007 |
| Income Tax Expense/Benefit |
100.00%
0.016
|
0.008 | 0.114 | -0.014 | 0.007 |
| Income/Loss From Continuing Operations After Tax |
57.92%
-20.77
|
-13.15 | -35.34 | 23.04 | 98.46 |
Net Income/Loss
|
57.92%
-20.77
|
-13.15 | -35.34 | 23.04 | 98.46 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | -0.177 | 17.57 | 94.11 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2.99%
10.83
|
10.51 | 1.935 | 5.5463 | 1.0341 |
| Diluted Average Shares |
2.99%
10.83
|
10.51 | 0.9554 | 10.78 | 7.6533 |
| Basic Earnings Per Share |
53.60%
-1.92
|
-1.25 | -7.95 | 0.98 | 4.21 |
| Diluted Earnings Per Share |
53.60%
-1.92
|
-1.25 | 1.72 | -2.83 | -14.07 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | -0.354 | 35.15 | 188.22 |
0.22%
3.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):